Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy.

Subjects: Azacitidine*/Azacitidine*/Azacitidine*/adverse effects ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/genetics

  • Source: Blood [Blood] 2022 Oct 27; Vol. 140 (17), pp. 1845-1857.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

Record details

×
  • 1-10 of  57 results for ""Lee, Je-Hwan""